Nuvalent, Inc. (NUVL)
NASDAQ·Healthcare·Biotechnology
$101.81
—
Mkt Cap $7.97B
Analyst Ratings
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
Implied Upside
+35.0%
Consensus $137.44 vs current $101.81
NASDAQ·Healthcare·Biotechnology
$101.81
—
Mkt Cap $7.97B
Buy
12
Hold
0
Sell
0
Price Target (20 analysts)
$137.44
Range $120.00 – $155.00
+35.0%
Consensus $137.44 vs current $101.81